| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |